Repeated listening to favorite music induces beneficial brain plasticity in Alzheimer’s patients

Researchers at the University of Toronto (U of T) and Unity Health Toronto have demonstrated that repeated listening to personally meaningful music induces beneficial brain plasticity in patients with mild cognitive impairment or early Alzheimer's disease. Changes in the brain's neural pathways correlated with increased memory performance on neuropsychological tests, supporting the clinical potential of personalized, music-based interventions for people […]

Read more

Testing for inflammatory proteins will help diagnose earlier onset, progression of Alzheimer’s disease

Testing for some inflammatory proteins associated with the nervous and immune systems will help diagnose the earlier onset and progression of Alzheimer's disease, according to a Rutgers study. The study, published in the journal Nature Communications, analyzed 15 cerebrospinal fluid proteins related to cells in the nervous and immune systems in 382 participants. The researchers found that a group of […]

Read more

Zero Benefit of Aducanumab for Alzheimers Disease, Panel Rules

An influential, independent panel unanimously voted that aducanumab (Aduhelm) offers no benefit for patients with Alzheimer’s disease (AD), adding to growing opposition from medical experts to the US Food and Drug Administration’s (FDA’s) approval of this controversial drug. The Institute for Clinical and Economic Review (ICER) asked one of its expert panels, the California Technology Assessment Forum, to consider the […]

Read more

Paying billions for controversial Alzheimer’s drug? How about funding this instead?

If you could invest $56 billion each year in improving health care for older adults, how would you spend it? On a hugely expensive medication with questionable efficacy — or something else? This isn't an abstract question. Aduhelm, a new Alzheimer's drug approved by the Food and Drug Administration last month, could be prescribed to 1 million to 2 million […]

Read more

‘Precision’ Nutrition? DHA Benefit Modified by AD Genetic Risk

In cognitively unimpaired middle-aged adults at high genetic risk for Alzheimer’s disease (AD), higher intake of dietary docosahexaenoic acid (DHA) was associated with greater resistance to disease-related brain atrophy on neuroimaging.    DHA intake, measured using a food frequency questionnaire, was found to be significantly related to greater cortical thickness, the AD signature in individuals homozygous for APOE-ε4, that is […]

Read more

Researchers test novel gene regulation approach to treat brain diseases

Researchers at the DZNE (Germany), at Massachusetts General Hospital (USA) and at the genomic medicine company Sangamo Therapeutics, Inc. tested a novel gene regulation approach to treat brain diseases such as Alzheimer's in laboratory studies. It leverages zinc finger proteins, which specifically bind to the DNA that codes for the protein Tau without altering it, thereby reducing Tau production in […]

Read more

Dementia: The fruit snack you should eat every week to protect against Alzheimer’s disease

Dementia is the name given to a group of symptoms linked to an ongoing decline in brain function. You could lower your risk of the neurodegenerative condition by regularly eating berries, it’s been revealed. There are a number of different types of dementia, and the most common in the UK is Alzheimer’s disease. Diagnosing the condition early could help to […]

Read more

New hope: German doctor to have discovered a cure for Alzheimer’s

A German scientist may have discovered a drug against dementia-diseases that can make the memory loss undo. Animal experiments with the new drug breakthrough results – a clinical study with Alzheimer’s patients. To show whether the active ingredient with the name Triple-Receptor Agonist, also shows in people’s success. 200 Alzheimer’s patients take part in the study in England, you get […]

Read more

Can Alzheimer’s be disease, also transmitted to other people?

Transferability of the pathological Amyloid-Beta proteins confirmed Alzheimer’s is a dreaded neurodegenerative disorder that primarily affects older people and their proliferation has increased in the past decades dramatically. Already in the year 2015, researchers had expressed the end of the Univesity College London suspected that a Transferability of the disease, the misfolded Amyloid-could be proteins. In laboratory tests on mice, […]

Read more